William Patrick Burke - 06 Jan 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Human Resources Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for William Patrick Burke
Issuer symbol: NVCR
Transactions as of: 06 Jan 2023
Net transactions value: +$6,729
Form type: 4
Filing time: 10 Jan 2023, 15:13:50 UTC
Previous filing: 06 Sep 2022
Next filing: 02 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$6,729	+108	+0.19%	$62.30	55,594	06 Jan 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
F2	In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022.